Study Finds Antimalarial Treatment Can Help Protect Against Cardiac Disease in Lupus

A new study published in the medical journal Rheumatology found that the antimalarial treatment hydroxychloroquine was associated with lowered risk for cardiac disease.  Factors that increased risk included prior cardiac complications, pulmonary involvement, greater lupus severity and lower socioeconomic status. Read more as reported by MedPageToday.